Propella Therapeutics clinical trials
Acquired by Astellas Pharma Inc, Dec 21, 2023 · source ↗
The registry lists 2 studies whose lead sponsor is Propella Therapeutics. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 31, 2024.
Before and after it joined Astellas Pharma Inc
- First submitted before Propella Therapeutics became part of Astellas Pharma Inc
- 2
- First submitted after Propella Therapeutics became part of Astellas Pharma Inc
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Propella Therapeutics2 studies
Something wrong with this grouping? Tell us on the Astellas Pharma Inc page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Astellas Pharma Inc studies →
- Osteoarthritis Knee Pain Relief Study of 0.25% 920-CGS-200CompletedNCT03124407Phase 4
Sponsor listed in the registry: Propella Therapeutics · First submitted before Propella Therapeutics became part of Astellas Pharma Inc
- A Phase 2 Clinical Trial Examining the Effects on Osteoarthritic Knee Pain of CGS-200-1, CGS-200-5 and Vehicle ControlCompletedNCT03528369Phase 2
Sponsor listed in the registry: Propella Therapeutics · First submitted before Propella Therapeutics became part of Astellas Pharma Inc